InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: Money $hot post# 15069

Thursday, 09/30/2021 4:48:15 PM

Thursday, September 30, 2021 4:48:15 PM

Post# of 16698
As I have said, COVID for AGN is done. Too expensive to go to a Phase 3 Trial with way less pertinence now. Probably why the FDA responses were not shared. There apparently were strong enough "trends" and 'signals' seen so that they will turned into valid FDA applications and CTs for Ifenprodil.

AGN is working toward the continued concepts of NDMA actions on the lungs. Now as both a CC remedy and for tumors due to some IL-6/low O2 data for Proof of Concept/whatever.

I should have referred to one of my previous posts re; REM/Wuhan V.I./Gilead/FDA/CCP. The post was supposed to be sadly funny.
BUT.
Ifenprodil 'may' have been a better treatment than REM, IMHFO. NA. Certainly does 'no damage' and 'may' have helped.
Few are arguing about the bad Safety record of Remdeathisnear.

PFE is working on a PFIzermectin type 'new drug' for COVID treatments.

No one is saying Ifenprodil treatments for Lung affected diseases may be un-Safe.?. "Powered' Phase 2 for Ifenprodil Chronic Cough CT.

Finally, we can expect better management handling of the paths forward. There are obvious improvements already.

There is strong support from AGN's SMEs. It's very encouraging to have our experts do the talking, in PRs ect, about continuous developments in the company's projects...GLTA...

Maybe LS* can do a PP until we get a BP partner's/sponsor's $$$.
Thanks for the past support from the 5...